TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Wed Feb 15

NL

Article

EBCapitalMarkets published an article 2:22 PM

Why Amgen's Becoming One of My Top Dividend Stocks to Buy

News that Amgen's Repatha lowers the risk of major cardiovascular events could clear the way for this medicine to achieve billion-dollar blockbuster status.

Mon Feb 13

NL

Article

EBCapitalMarkets published an article 8:00 AM

3 Stocks You Can Still Buy With the Market at Record Highs

Despite a big run-up in stock prices, there are still reasons investors can buy top stocks, like Pfizer, Cliffs Natural Resources, and Chicago Bridge & Iron.

Sun Feb 12

NL

Article

EBCapitalMarkets published an article 10:05 PM

Top 5 States for Marijuana Stocks

Interest in marijuana stocks is exploding as Americans increasingly pass medical and recreational marijuana laws. Here are the five states that could offer marijuana stocks the most upside by 2021.

NL

Article

EBCapitalMarkets published an article 8:41 AM

Is Merrimack Pharmaceuticals Worth Stashing in Portfolios?

This biotech hopes to recapture its luster following a major restructuring.

Sat Feb 11

NL

Article

EBCapitalMarkets published an article 10:00 PM

Will Seattle Genetics' Deal With Immunomedics Get Scuttled?

A licensing deal with Immunomedics lands Seattle Genetics an intriguing late-stage drug for its pipeline.

Fri Feb 10

NL

Article

EBCapitalMarkets published an article 4:20 PM

Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017

Tesaro's stock is surging higher ahead of the potential approval of a game-changing drug for ovarian cancer.

NL

Article

EBCapitalMarkets published an article 2:59 PM

Investing Rookie? Start With These 3 Stocks

Our Motley Fool contributors think that new investors can benefit from owning shares in Pfizer, ExxonMobil, and Disney.

NL

Article

EBCapitalMarkets published an article 1:34 PM

What's Better: Claiming Social Security at 62 or 66?

Breakeven analysis offers insight into whether it pays off to take Social Security benefits early or wait until full retirement age to claim them.

NL

Article

EBCapitalMarkets published an article 8:22 AM

Is Array BioPharma the Best Clinical-Stage Biotech Stock to Buy in 2017?

Array BioPharma could be on the cusp of transitioning from a clinical- to commercial-stage company this year.

NL

Article

EBCapitalMarkets published an article 12:00 AM

Better Buy: Illumina or Gilead Sciences?

We’re pitting off gene sequencing giant Illumina against giant biotech Gilead Sciences to see which company is the better buy for long-term investors.

Thu Feb 9

NL

Article

EBCapitalMarkets published an article 3:51 PM

3 Stocks Begging for a Buyout

Here's why it could make sense for Twitter, GoPro, and Merrimack Pharmaceuticals to get acquired.

NL

Article

EBCapitalMarkets published an article 3:21 PM

Why bluebird bio Stock Surged 20.7% Higher in January

Optimism soared after management updated investors on the progress it's making on its clinical-stage gene therapy pipeline.

NL

Article

EBCapitalMarkets published an article 2:51 PM

3 Beaten-Down Stocks Ready to Bounce Back

Here's how Regeneron Pharmaceuticals, Royal Dutch Shell, and United Parcel Service can get back to rewarding investors with gains.

Wed Feb 8

NL

Article

EBCapitalMarkets published an article 11:18 PM

Anthem and Cigna's Blockbuster Merger Is Blocked

Judges have determined that the merger does little to improve competition among insurers.

Tue Feb 7

NL

Article

EBCapitalMarkets published an article 8:19 PM

Gilead Sciences Just Shocked Investors, And It Wasn't Good

New sales guidance for Gilead Sciences suggests that the company's struggles could continue to disappoint investors this year.

NL

Article

EBCapitalMarkets published an article 3:36 PM

Why Crisper Therapeutics Tumbled 12.4% in January

Crisper Therapeutics' innovative new approach to tacking genetic disease failed to excite investors' interest last month.

NL

Article

EBCapitalMarkets published an article 1:54 PM

Could Donald Trump's Travel Ban Be Bad Medicine?

Biotech leaders rally to convince the White House of the importance of immigration to their research efforts.

Mon Feb 6

NL

Article

EBCapitalMarkets published an article 4:42 PM

Why Merrimack Pharmaceuticals Got Crushed 23.8% in January

Investors fled the stock after the company announced a major restructuring of its business.

NL

Article

EBCapitalMarkets published an article 4:21 PM

Why Illumina, Inc. Soared 25% in January

Excitement ahead of the launch of two next-generation gene-sequencing machines sent shares soaring last month.

NL

Article

EBCapitalMarkets published an article 8:41 AM

This Marijuana Stock Is Already Worth $1 Billion -- Is It a Buy?

Canopy Growth Corporation's generating eye-popping returns for investors. However, there are risks ahead that could rein in some investor optimism.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 65476 out of 74626
Score -646.41
Score Change Today -58.05
Accuracy 32.00%
Active Picks 47
Total Picks 52
Best Pick MDVN.DL (+145.92)
Worst Pick OPHT (-107.23)
Average Score per Pick -12.43
Charms Earned 2
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts